These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18481170)

  • 1. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
    Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
    Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
    Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.
    Vrieling A; Voskuil DW; Bosma A; Majoor DM; van Doorn J; Cats A; Depla AC; Timmer R; Witteman BJ; Wesseling J; Kampman E; Van't Veer LJ
    Growth Horm IGF Res; 2009 Apr; 19(2):126-35. PubMed ID: 18801683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and prognostic significance in epithelial ovarian cancer].
    Katsaros D; Yu H; Piccinno R; Puopolo M; Rigault De La Longrais IA; Fracchioli S; Massobrio M
    Minerva Ginecol; 2002 Feb; 54(1):15-24. PubMed ID: 11828267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
    Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
    Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-like growth factors (IGF), FSH, and leptin on IGF-binding-protein mRNA expression in bovine granulosa and theca cells: quantitative detection by real-time PCR.
    Voge JL; Aad PY; Santiago CA; Goad DW; Malayer JR; Allen D; Spicer LJ
    Peptides; 2004 Dec; 25(12):2195-203. PubMed ID: 15572210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
    Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
    Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
    Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
    Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and function of IGFBP-3 in normal and malignant breast tissue.
    McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
    Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
    Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
    Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
    Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.